4.5 Article

Expression pattern of lncRNAs in pituitary adenomas

Related references

Note: Only part of the references are listed.
Article Oncology

Management after initial surgery of nonfunctioning pituitary adenoma: surveillance, radiotherapy or surgery?

Thomas Charleux et al.

Summary: The first line of treatment for nonfunctioning pituitary adenoma (NFPA) is surgery. Adjuvant radiotherapy or surveillance and new treatment (second surgical operation or salvage radiotherapy) in case of recurrence are options discussed at the multidisciplinary tumor board. The purpose of this study was to evaluate the therapeutic outcome for each option. Results showed that adjuvant radiotherapy was not superior to salvage radiotherapy in preventing recurrence, therefore salvage radiotherapy is recommended in case of recurrence or progression to avoid a second surgical operation.

RADIATION ONCOLOGY (2022)

Article Oncology

Expression pattern of non-coding RNAs in non-functioning pituitary adenoma

Soudeh Ghafouri-Fard et al.

Summary: This study identified differentially expressed genes (DEGs), including long non-coding RNAs (DElncRNAs) and microRNAs (DEmiRNAs), in non-functioning pituitary adenomas (NFPA) compared to normal samples. The study also assessed the relationship between these genes and important signaling pathways. The findings revealed dysregulated pathways and differential expression of several genes in NFPA.

FRONTIERS IN ONCOLOGY (2022)

Review Oncology

The Emerging Role of Non-Coding RNAs in Pituitary Gland Tumors and Meningioma

Soudeh Ghafouri-Fard et al.

Summary: Non-coding RNAs have been shown to play a significant role in the pathogenesis of pituitary gland tumors and meningiomas. Further research is needed to explore their potential applications as biomarkers for diagnosis and treatment in these brain tumors.

CANCERS (2021)

Review Clinical Neurology

The Role of Long Noncoding RNAs in the Biology of Pituitary Adenomas

Ozal Beylerli et al.

WORLD NEUROSURGERY (2020)

Review Medicine, General & Internal

Long Non-coding RNAs in Cancer: Implications for Diagnosis, Prognosis, and Therapy

Yuchen Qian et al.

FRONTIERS IN MEDICINE (2020)

Article Endocrinology & Metabolism

European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas

Gerald Raverot et al.

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2018)

Review Biochemistry & Molecular Biology

The emerging role of IncRNAs in cancer

Maite Huarte

NATURE MEDICINE (2015)

Review Oncology

Epidemiology and etiopathogenesis of pituitary adenomas

Elena D. Aflorei et al.

JOURNAL OF NEURO-ONCOLOGY (2014)

Review Biochemistry & Molecular Biology

Molecular Mechanisms of Long Noncoding RNAs

Kevin C. Wang et al.

MOLECULAR CELL (2011)

Article Endocrinology & Metabolism

Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK)

Alberto Fernandez et al.

CLINICAL ENDOCRINOLOGY (2010)

Article Endocrinology & Metabolism

Factors predicting relapse of nonfunctioning pituitary macroadenomas after neurosurgery: a study of 142 patients

Sophie Brochier et al.

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2010)

Article Multidisciplinary Sciences

A coding-independent function of gene and pseudogene mRNAs regulates tumour biology

Laura Poliseno et al.

NATURE (2010)

Review Endocrinology & Metabolism

Treatment and follow-up of clinically nonfunctioning pituitary macroadenomas

O. M. Dekkers et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)